Why is Aarti Drugs falling/rising?

As of 31-Jul, Aarti Drugs Ltd is experiencing a decline in its stock price, currently at 506.55, reflecting a decrease of 15.0 points or 2.88%. The stock has underperformed its sector by 1.39% today and has been on a downward trend for the last two days, accumulating a total loss of 5.99%. It opened with a loss of 2.95% and reached an intraday low of Rs 503.2. In terms of performance over various periods, the stock has shown a 1-week decline of 5.86% and a 1-year return of -0.92%, despite a positive 1-month return of 7.89%. The company maintains a high management efficiency with a return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45, which suggests a stable financial position. However, the stock is trading at a discount compared to its peers, and while profits have risen by 20.4% over the past year, the stock's recent performance may be influenced by its consecutive losses and underperformance relative to the sector. In the broader market context, Aarti Drugs' recent performance contrasts with the Sensex, which has only declined by 1.22% over the past week. This indicates that the stock's short-term return is significantly worse than the benchmark, suggesting that investor sentiment may be more negative towards Aarti Drugs compared to the overall market. The rising investor participation, evidenced by a 46.15% increase in delivery volume, could indicate potential interest from buyers, but the current price movement reflects a cautious market response. Overall, while the company has strong fundamentals, the recent price decline may be attributed to short-term market dynamics and investor sentiment rather than underlying financial health.